SECreport

Form 4 INOVIO PHARMACEUTICALS, For: Feb 28 Filed by: Sumner Michael John

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx